Nanobiotix SA (NBTX)
6.10
+0.05
(+0.83%)
USD |
NASDAQ |
May 03, 16:00
6.20
+0.10
(+1.64%)
After-Hours: 20:00
Nanobiotix 1 Year Total Returns (Daily): 208.1% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 208.1% |
| May 02, 2024 | 181.4% |
| May 01, 2024 | 203.0% |
| April 30, 2024 | 172.9% |
| April 29, 2024 | 171.5% |
| April 26, 2024 | 125.5% |
| April 25, 2024 | 130.0% |
| April 24, 2024 | 37.85% |
| April 23, 2024 | 52.67% |
| April 22, 2024 | 53.20% |
| April 19, 2024 | 44.65% |
| April 18, 2024 | 39.24% |
| April 17, 2024 | 36.20% |
| April 16, 2024 | 39.75% |
| April 15, 2024 | 41.52% |
| April 12, 2024 | 54.18% |
| April 11, 2024 | 56.46% |
| April 10, 2024 | 66.15% |
| April 09, 2024 | 64.70% |
| April 08, 2024 | 72.92% |
| April 05, 2024 | 83.57% |
| April 04, 2024 | 61.32% |
| April 03, 2024 | 73.90% |
| April 02, 2024 | 73.05% |
| April 01, 2024 | 75.89% |
| Date | Value |
|---|---|
| March 28, 2024 | 80.55% |
| March 27, 2024 | 84.06% |
| March 26, 2024 | 78.26% |
| March 25, 2024 | 77.39% |
| March 22, 2024 | 80.29% |
| March 21, 2024 | 88.41% |
| March 20, 2024 | 79.71% |
| March 19, 2024 | 80.00% |
| March 18, 2024 | 82.03% |
| March 15, 2024 | 100.3% |
| March 14, 2024 | 64.74% |
| March 13, 2024 | 81.94% |
| March 12, 2024 | 91.97% |
| March 11, 2024 | 93.40% |
| March 08, 2024 | 88.24% |
| March 07, 2024 | 79.14% |
| March 06, 2024 | 82.81% |
| March 05, 2024 | 87.06% |
| March 04, 2024 | 85.36% |
| March 01, 2024 | 83.24% |
| February 29, 2024 | 77.56% |
| February 28, 2024 | 89.20% |
| February 27, 2024 | 86.40% |
| February 26, 2024 | 85.19% |
| February 23, 2024 | 87.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.12%
Minimum
Jul 29 2022
232.3%
Maximum
Jul 31 2023
-2.57%
Average
-50.44%
Median
Dec 08 2022
1 Year Total Returns (Daily) Benchmarks
| DBV Technologies SA | -57.25% |
| Cellectis SA | 60.75% |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | -14.33% |
| Innate Pharma SA | -11.92% |